Scaffold hopping, synthesis and structure–activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: A novel series of CB1 receptor antagonistsJonas Boström, Michael Wilstermann, Peter J. Greasley et al.|Bioorganic & Medicinal Chemistry|2007Cited by 66